Psychosocial Stressors and Alcohol use,Severity,and Treatment Receipt across Human Immunodeficiency virus (HIV) Status in a Nationally Representative Sample of US Residents
Restricted accessResearch articleFirst published online July, 2017
Psychosocial Stressors and Alcohol use,Severity,and Treatment Receipt across Human Immunodeficiency virus (HIV) Status in a Nationally Representative Sample of US Residents
Human immunodeficiency virus (HIV) is stigmatized and disproportionately impacts vulnerable populations. Thus, people living with HIV (PLWH) may have greater exposure to psychosocial stressors than those without HIV. Exposure to psychosocial stressors may increase alcohol use and serve as barriers to alcohol treatment receipt. The authors evaluate whether psychosocial stressors and alcohol use, symptom severity, and treatment receipt vary across HIV status in a general population sample of US residents and assess whether psychosocial stressors mediate identified associations.
Methods
Data from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) were used to assess associations between HIV status and psychosocial stressors (perceived stress, alcohol-related stigma, and perceived discrimination based on race/ethnicity, sexual orientation, or sex) and alcohol-related outcomes (any use, heavy drinking, symptom severity, and treatment receipt). For each outcome, regression models were fit and iteratively adjusted for sociodemographic characteristics and comorbidities. Indirect effects of HIV on alcohol-related outcomes through stressors were estimated to assess mediation when main effects were significant.
Results
Among 34,653 NESARC Wave 2 respondents, 161 were PLWH. PLWH were more likely than those without HIV to experience discrimination and had higher levels of perceived stress than those without HIV (P values <.05), but the 2 groups did not differ regarding alcohol-related stigma. PLWH were less likely to use alcohol and had similar rates of heavy drinking relative to participants without HIV, but alcohol symptom severity and treatment receipt were greater among PLWH. Perceived stress but not discrimination mediated associations.
Conclusions
Findings from this first study of variation in psychosocial stressors and alcohol use, severity, and treatment receipt across HIV status further highlight PLWH as a population that is particularly vulnerable to experiences of psychosocial stress and certain adverse alcohol-related outcomes. Future longitudinal research is needed in a larger sample of PLWH to identify intervention targets.
JusticeAC, McGinnisKA, TateJP, . Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend.2016;161:95–103.
2.
SametJH, FreedbergKA, SteinMD, . Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med.1998;158:734–740.
3.
SametJH, FreedbergKA, SavetskyJB, SullivanLM, SteinMD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS.2001;15:77–85.
4.
MonroeAK, LauB, MugaveroMJ, . Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr.2016;73(4):419-425.
5.
HendershotCS, StonerSA, PantaloneDW, SimoniJM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr.2009;52:180–202.
6.
VagenasP, AzarMM, CopenhaverMM, SpringerSA, MolinaPE, AlticeFL. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care. Curr HIV/AIDS Rep.2015;12:421–436.
Scott-SheldonLA, CareyKB, CunninghamK, JohnsonBT, CareyMP. Alcohol use predicts sexual decision-making: a systematic review and meta-analysis of the experimental literature. AIDS Behav.2016;(20 Suppl 1):19–39.
9.
GalvanFH, BingEG, FleishmanJA, . The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol.2002;63:179–186.
10.
SametJH, PhillipsSJ, HortonNJ, TraphagenET, FreedbergKA. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses.2004;20:151–155.
11.
LefevreF, O'LearyB, MoranM, MossarM, YarnoldPR, MartinGJ. Alcohol consumption among HIV-infected patients. J Gen Intern Med.1995;10:458–460.
ChambersLA, RuedaS, BakerDN, . Stigma, HIV and health: a qualitative synthesis. BMC Public Health.2015;15:848.
14.
EvansS, FerrandoSJ, RabkinJG, FishmanB. Health locus of control, distress, and utilization of protease inhibitors among HIV-positive men. J Psychosom Res.2000;49:157–162.
15.
PreauM, VincentE, SpireB, . Health-related quality of life and health locus of control beliefs among HIV-infected treated patients. J Psychosom Res.2005;59:407–413.
16.
SteptoeA, WardleJ. Locus of control and health behaviour revisited: a multivariate analysis of young adults from 18 countries. Br J Psychol2001;92(Pt 4):659–672.
17.
HarrisAH, BradleyKA, BoweT, HendersonP, MoosR. Associations between AUDIT-C and mortality vary by age and sex. Popul Health Manag.2010;13:263–268.
18.
GrantBF, GoldsteinRB, SahaTD, . Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry.2015;72:757–766.
19.
HallHI, EspinozaL, BenbowN, HuYW, Urban AreasHIVSW. Epidemiology of HIV infection in large urban areas in the United States. PLoS ONE.2010;5:e12756.
20.
HallHI, GeduldJ, BoulosD, . Epidemiology of HIV in the United States and Canada: current status and ongoing challenges. J Acquir Immune Defic Syndr.2009;51(Suppl 1):S13–S20.
21.
LanskyA, BrooksJT, DiNennoE, HeffelfingerJ, HallHI, MerminJ. Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr.2010;55(Suppl 2):S64–S68.
22.
MuliaN, YeY, GreenfieldTK, ZemoreSE. Disparities in alcohol-related problems among white, black, and Hispanic Americans. Alcohol Clin Exp Res.2009;33:654–662.
23.
MuliaN, YeY, ZemoreSE, GreenfieldTK. Social disadvantage, stress, and alcohol use among black, Hispanic, and white Americans: findings from the 2005 U.S. National Alcohol Survey. J Stud Alcohol Drugs.2008;69:824–833.
24.
PellowskiJA, KalichmanSC, MatthewsKA, AdlerN. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol.2013;68:197–209.
25.
KellyUA. Integrating intersectionality and biomedicine in health disparities research. Adv Nurs Sci.2009;32:E42–E56.
26.
PeraltaR. Raced and gendered reactions to the deviance of drunkenness: a sociological analysis of race and gender disparities in alcohol use. Contemp Drug Probl.2010;37:381–415.
27.
CrispAH, GelderMG, RixS, MeltzerHI, RowlandsOJ. Stigmatisation of people with mental illnesses. Br J Psychiatry.2000;177:4–7.
28.
SchomerusG, LuchtM, HolzingerA, MatschingerH, CartaMG, AngermeyerMC. The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol.2011;46:105–112.
29.
KellyJF, WesterhoffCM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy.2010;21:202–207.
30.
GlassJE, MowbrayOP, LinkBG, KristjanssonSD, BucholzKK. Alcohol stigma and persistence of alcohol and other psychiatric disorders: a modified labeling theory approach. Drug Alcohol Depend.2013;133:685–692.
31.
KeyesKM, HatzenbuehlerML, McLaughlinKA, . Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol.2010;172:1364–1372.
32.
SadavaSW, PakA. Stress-related problem drinking and alcohol problems: a longitudinal study and extension of Marlatt's model. Can J Behav Sci.1993;25:446–464.
33.
SadavaSW, ThistleR, ForsythR. Stress, escapism and patterns of alcohol and drug use. J Stud Alcohol.1978;39:725–736.
34.
JennisonKM. The impact of stressful life events and social support on drinking among older adults: a general population survey. Int J Aging Hum Dev.1992;35:99–123.
35.
HasinDS, GrantBF. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Psychiatr Epidemiol.2015; 50(11):1609–1640.
36.
VeenstraMY, LemmensPH, FriesemaIH, GarretsenHF, KnottnerusJA, ZwieteringPJ. A literature overview of the relationship between life-events and alcohol use in the general population. Alcohol Alcohol.2006;41:455–463.
37.
PohoreckyLA. Stress and alcohol interaction: an update of human research. Alcohol. Clin Exp Res.1991;15:438–459.
38.
McIntoshRC, RosselliM. Stress and coping in women living with HIV: a meta-analytic review. AIDS Behav.2012;16:2144–2159.
39.
ChidaY, VedharaK. Adverse psychosocial factors predict poorer prognosis in HIV disease: a meta-analytic review of prospective investigations. Brain Behav Immun.2009;23:434–445.
40.
GrantBF, GoldsteinRB, ChouSP, . Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry.2009;14:1051–1066.
41.
GrantBF, StinsonFS, DawsonDA, . Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry.2004;61:807–816.
42.
FultzSL, SkandersonM, MoleLA, . Development and verification of a “virtual” cohort using the National VA Health Information System. Med Care.2006;44(8 Suppl 2):S25–S30.
43.
JusticeAC, DombrowskiE, ConigliaroJ, . Veterans Aging Cohort Study (VACS): overview and description. Med Care.2006;44(8 Suppl 2):S13–S24.
44.
SmithP, SchmidtSM, Allensworth-DaviesD, SaitzR. Primary care validation of a single-question alcohol screening test. J Gen Intern Med.2009;24:783–788.
45.
GrantBF, DawsonDA, HasinDS. The Alcohol Use Disorder and Associated Disabilities Interview Schedule—DSM-IV Version.Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2001.
46.
GrantBF, DawsonDA, StinsonFS, ChouPS, KayW, PickeringR. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend.2003;71:7–16.
47.
RuanWJ, GoldsteinRB, ChouSP, . The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend.2008;92:27–36.
48.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.4th ed. (text rev.). Washington, DC: American Psychiatric Association; 2000.
49.
DawsonDA, GrantBF, StinsonFS, ChouPS. Estimating the effect of help-seeking on achieving recovery from alcohol dependence. Addiction.2006;101:824–834.
50.
CarlinerH, DelkerE, FinkDS, KeyesKM, HasinDS. Racial discrimination, socioeconomic position, and illicit drug use among US Blacks. Soc Psychiatry Psychiatr. Epidemiol.2016; 51(4):551–560.
51.
McCabeSE, BostwickWB, HughesTL, WestBT, BoydCJ. The relationship between discrimination and substance use disorders among lesbian, gay, and bisexual adults in the United States. Am J Public Health.2010;100:1946–1952.
52.
KriegerN, SmithK, NaishadhamD, HartmanC, BarbeauEM. Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med.2005;61:1576–1596.
53.
CohenS, WilliamsonG. Perceived stress in a probability sample of the United States. In: SpaceapamS, OskampS, eds. The Social Psychology of Health: Claremont Symposium on Applied Social Psychology.Thousand Oaks, CA: Sage; 1988:31–67.
54.
LinkBG. Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. Am Sociol Rev.1987;52:96–112.
GlassJE, WilliamsEC, BucholzKK. Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder. Alcohol Clin Exp Res.2014;38:1697–1705.
57.
Office of Management and Budget, United States Government. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. http://www.whitehouse.gov/omb/fedreg_1997standards/. Published 1997. Accessed January 262015.
58.
HebertPL, SiskJE, HowellEA. When does a difference become a disparity? Conceptualizing racial and ethnic disparities in health. Health Aff (Millwood).2008;27:374–382.
59.
MacKinnonDP. Contrast in multiple mediator models. In: Rose J, Chassin L, Presson C, Sherman S, eds.Multivariate Applications in Substance Use Research: New Methods for New Questions.Mahwah, NJ: Lawrence Erlbaun Associates; 2000:141–160.
60.
MackinnonDP, WarsiG, DwyerJH. A simulation study of mediated effect measures. Multivariate Behav Res.1995;30:41.
61.
HasinDS, StinsonFS, OgburnE, GrantBF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry.2007;64:830–842.
SmithSM, DawsonDA, GoldsteinRB, GrantBF. Examining perceived alcoholism stigma effect on racial-ethnic disparities in treatment and quality of life among alcoholics. J Stud Alcohol Drugs.2010;71:231–236.
65.
CohenE, FeinnR, AriasA, KranzlerHR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend.2007;86:214–221.
66.
ShuperPA, NeumanM, KanteresF, BaliunasD, JoharchiN, RehmJ. Causal considerations on alcohol and HIV/AIDS—a systematic review. Alcohol Alcohol.2010;45:159–166.
67.
WilliamsEC, PalfaiT, ChengDM, . Physical health and drinking among medical inpatients with unhealthy alcohol use: a prospective study. Alcohol Clin Exp Res.2010;34:1257–1265.
68.
SametJH, ChengDM, LibmanH, NunesDP, AlperenJK, SaitzR. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr.2007;46:194–199.
69.
JusticeAC, LaskyE, McGinnisKA, . Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care.2006;44(8 Suppl 2):S52–S60.
70.
PossematoK, FunderburkJ, SpinolaS, . Reliability and validity of a treatment barriers scale for individuals with alcohol use disorder. Subst Use Misuse.2016;51:383–394.
71.
WilliamsEC, HortonNJ, SametJH, SaitzR. Do brief measures of readiness to change predict alcohol consumption and consequences in primary care patients with unhealthy alcohol use?Alcohol Clin Exp Res.2007;31:428–435.
72.
OrfordJ, HodgsonR, CopelloA, . The clients’ perspective on change during treatment for an alcohol problem: qualitative analysis of follow-up interviews in the UK Alcohol Treatment Trial. Addiction.2006;101:60–68.
73.
McGinnisKA, FiellinDA, TateJP, . Number of drinks to “feel a buzz” by HIV status and viral load in men. AIDS Behav.2016;20:504–511.
74.
JusticeAC, McGinnisKA, TateJP, . Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend.2016;161:95–103.
75.
HahnJA, SametJH. Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep.2010;7:226–233.
76.
ShapiroMF, MortonSC, McCaffreyDF, . Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA.1999;281:2305–2315.
77.
VolpicelliJR. Uncontrollable events and alcohol drinking. Br J Addict.1987;82:381–392.
78.
PescosolidoBA, MartinJK, LongJS, MedinaTR, PhelanJC, LinkBG. “A disease like any other”? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry.2010;167:1321–1330.
79.
HerekGM, CapitanioJP, WidamanKF. HIV-related stigma and knowledge in the United States: prevalence and trends, 1991–1999. Am J Public Health.2002;92:371–377.
80.
SchutteKK, BrennanPL, MoosRH. Remission of late-life drinking problems: a 4-year follow-up. Alcohol Clin Exp Res.1994;18:835–844.
81.
GilbertPA, ZemoreSE. Discrimination and drinking: a systematic review of the evidence. Soc Sci Med.2016;161:178–194.
